Role of heparin in the antithrombotic treatment of valvulopathies

Journal of Heart Valve Disease

Volumn 13, Issue 3, 2004, Pages 339-343

  Hanania, Guy ^a  

^a Centre Hospitalier Robert Ballanger CHRB   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; HEPARIN;

DRUG CONTRAINDICATION; FEMALE; HEART VALVE PROSTHESIS; HUMAN; PREGNANCY; PREGNANCY COMPLICATION; REVIEW; THROMBOEMBOLISM; VALVULAR HEART DISEASE;

ANTICOAGULANTS; FEMALE; HEART VALVE DISEASES; HEART VALVE PROSTHESIS; HEPARIN; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; THROMBOEMBOLISM;

EID: 5144228241     PISSN: 09668519     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (29)

1. Gohlke-Bärwolf C, Oakley C, Butchart E, et al. Guidelines for prevention of thromboembolic events in valvular heart disease. Eur Heart J 1995;16:1320-1330
2. Bonow RO, Carabelo B, DeLeon AC, et al. ACC/AHA guidelines for the management of patients with valvular heart disease. J Am Coll Cardiol 1998;32:1486-1588
3. Ginsberg JS, Greer I, Hirsh I. Use of antithrombotic agents during pregnancy. Chest 2001;119:122S-131S
4. Albers GW, Dalen JE, Laupacis A, et al. Antithrombotic therapy in atrial fibrillation. Chest 2001;119:194S-206S
5. Salem DN, Daudelin DH, Levine HJ, et al. Antithrombotic therapy in valvular heart disease. Chest 2001;119:207S-219S
6. Stein PD, Alpert JS, Bussey AJ, et al. Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves. Chest 2001;119:220S-227S
7. Butchart EG, Lewis P A, Bethel JA, Breckenridge IM. Adjusting anticoagulation to prosthesis throm-bogenicity and patient risk factors. Recommendations for the Medtronic Hall valve. Circulation 1991;84(Suppl. III):61-69
8. Iung B, Cormier B, Dadez E, et al. Small abnormal echos after mitral valve replacement with bileaflet mechanical prostheses: Predisposing factors and effect on thromboembolism. J Heart Valve Dis 1993;2:259-266
9. Laffort P, Roudaut R, Roques X, et al. Early and long-term (one-year) effects of the association of aspirin and oral anticoagulant on thrombi and morbidity after replacement of the mitral valve with the St. Jude Medical prosthesis. J Am Coll Cardiol 2000;35:739-746
10. Montalescot G, Polle V, Collet JP, et al. Low molecular weight heparin after mechanical heart valve replacement. Circulation 2000;101:1083-1086
11. Wahl MJ. Dental surgery in anticoagulated patients. Arch Intern Med 1998;158:1610-1616
12. Gohlke-Bärwolf C. Anticoagulation in valvular heart disease: New aspects and management during non-cardiac surgery. Heart 2000;84:567-572
13. Spandorfer JM, Lynch S, Weitz HH, et al. Use of enoxaparin for the chronically anticoagulated patient before and after procedures. Am J Cardiol 1999;84:478-480
14. Murray RD, Deitcher SR, Shah A, et al. Potential clinical efficacy and cost benefit of a transesophageal echocardiography-guided low-molecular weight heparin (enoxaparin) approach to antithrombotic therapy in patients undergoing immediate cardioversion from atrial fibrillation. J Am Soc Echocardiogr 2001;14:200-208
15. Harenberg J, Weuster B, Pfitzer M, et al. Prophylaxis of embolic events in patients with atrial fibrillation using low molecular weight heparin. Semin Thromb Hemost 1993;19(Suppl. 1):116-121
16. Ananthasubramanian K, Beattie EM, Rosman HS, Jayam V, Borzak S. How safely and for how long can warfarin therapy be withheld in prosthetic heart valve patients hospitalized with a major hemorrhage? Chest 2001;119:478-484
17. Badduke BR, Jamieson WR, Miyagishima RT, et al. Pregnancy and childbearing in population with biologic valvular prostheses. J Thorac Cardiovasc Surg 1991;102:179-186
18. Hall JG, Pauli RM, Wilson KM. Maternal and fetal sequelae of anticoagulation during pregnancy. Am J Med 1980;68:122-140
19. Sbarouni E, Oakley CM. Outcome of pregnancy in women with valve prostheses. Br Heart J 1994;71:196-201
20. Hanania G, Thomas D, Michel PL, et al. Pregnancy and prosthetic heart valves: A French cooperative retrospective study of 155 cases. Eur Heart J 1994;15:1651-1658
21. Larrea JL, Nunez L, Reque JA, Gil Aguado M, Matarros R, Minguez JA. Pregnancy and mechanical valve prostheses: A high-risk situation for the mother and the fetus. Ann Thorac Surg 1983;36:459-463
22. Salazar E, Zajarias A, Gutierrez N, Iturbe I. The problem of cardiac valve prostheses, anticoagulants, and pregnancy. Circulation 1984;70(Suppl. I):169-177
23. Iturbe-Alessio I, Fonseca MDC, Mutchinik O, Santos MA, Zajarias A, Salazar E. Risks of anticoagulant therapy in pregnant women with artificial heart valves. N Engl J Med 1986;315:1390-1393
24. Vitali E, Donatelli F, Quaini E, Groppelli G, Pellegrini A. Pregnancy in patients with mechanical prosthetic heart valves. Our experience regarding 98 pregnancies in 57 patients. J Cardiovasc Surg 1986;27:221-227
25. Sareli P, England MJ, Berk MR, et al. Maternal and fetal sequelae of anticoagulation during pregnancy in patients with mechanical heart valve prostheses. Am J Cardiol 1989;63:1462-1465
26. Born D, Martinez EE, Almeida P AM, et al. Pregnancy in patients with prosthetic heart valves: The effects of anticoagulation on mother, fetus, and neonate. Am Heart J 1992;124:413-417
27. Oakley CM. Anticoagulants in pregnancy. Br Heart J 1995;74:107-111
28. Vitale N, De Feo M, De Santo LS, et al. Dose-dependent fetal complications of warfarin in pregnant women with mechanical heart valves. J Am Coll Cardiol 1999;33:1637-1641
29. Cortufo M, de Luca TSL, Calabro R, et al. Coumarin anticoagulation during pregnancy in patients with mechanical valve prostheses. Eur J Cardiothorac Surg 1991;3:300-305